Vega Investment Solutions Acquires Shares of 10,284 The Cooper Companies, Inc. $COO

Vega Investment Solutions acquired a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COOFree Report) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 10,284 shares of the medical device company’s stock, valued at approximately $737,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Heartland Advisors Inc. acquired a new stake in Cooper Companies during the fourth quarter worth approximately $15,348,000. Mitsubishi UFJ Asset Management Co. Ltd. raised its holdings in Cooper Companies by 6.0% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 421,948 shares of the medical device company’s stock valued at $34,224,000 after acquiring an additional 23,896 shares during the last quarter. Swedbank AB lifted its stake in shares of Cooper Companies by 18.8% during the 4th quarter. Swedbank AB now owns 1,074,029 shares of the medical device company’s stock worth $88,027,000 after purchasing an additional 170,000 shares during the period. Capital International Inc. CA boosted its holdings in shares of Cooper Companies by 22.9% during the fourth quarter. Capital International Inc. CA now owns 118,210 shares of the medical device company’s stock worth $9,688,000 after purchasing an additional 22,054 shares during the last quarter. Finally, Tocqueville Asset Management L.P. purchased a new stake in shares of Cooper Companies in the second quarter valued at $1,502,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Cooper Companies Trading Down 0.6%

COO stock opened at $75.80 on Tuesday. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23. The company has a market cap of $14.78 billion, a price-to-earnings ratio of 64.24, a PEG ratio of 1.99 and a beta of 0.83. The business has a fifty day simple moving average of $72.09 and a 200-day simple moving average of $71.07. The Cooper Companies, Inc. has a 52 week low of $58.89 and a 52 week high of $89.83.

Cooper Companies (NASDAQ:COOGet Free Report) last issued its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The firm had revenue of $1.08 billion for the quarter, compared to analysts’ expectations of $1.05 billion. During the same quarter last year, the firm earned $0.96 earnings per share. The firm’s revenue for the quarter was up 7.9% compared to the same quarter last year. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. On average, equities research analysts expect that The Cooper Companies, Inc. will post 4.63 EPS for the current year.

Analyst Ratings Changes

Several research firms recently commented on COO. Piper Sandler set a $86.00 target price on Cooper Companies and gave the company an “overweight” rating in a research note on Monday, June 1st. Robert W. Baird decreased their price target on Cooper Companies from $98.00 to $85.00 and set an “outperform” rating on the stock in a research note on Friday, June 5th. Mizuho set a $85.00 price target on Cooper Companies and gave the company an “outperform” rating in a report on Thursday, June 4th. Stifel Nicolaus dropped their price objective on shares of Cooper Companies from $95.00 to $85.00 and set a “buy” rating for the company in a research note on Friday, June 5th. Finally, JPMorgan Chase & Co. cut their price objective on shares of Cooper Companies from $80.00 to $71.00 and set a “neutral” rating on the stock in a report on Friday, June 5th. One research analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, Cooper Companies presently has an average rating of “Hold” and a consensus price target of $81.64.

Read Our Latest Report on COO

Cooper Companies Profile

(Free Report)

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.

See Also

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COOFree Report).

Institutional Ownership by Quarter for Cooper Companies (NASDAQ:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.